Affiliation:
1. School of Computing Engineering and the Built Environment Glasgow Caledonian University Glasgow United Kingdom
2. Environmental Research Institute University of the Highlands and Islands Thurso United Kingdom
3. Health Care Without Harm Europe Brussels Belgium
4. NHS Highland Inverness United Kingdom
5. Emschergenossenschaft and Lippeverband Essen Germany
Abstract
AbstractThe present study reviews options for reducing harm from pharmaceuticals that are known to cause adverse impacts by their presence in the environment. It reviews recent global and European Union policy development, which could go further in recognizing and addressing the issue in a global context. It considers green chemistry, which can help clean up production processes but holds only long‐term promise for creating “green” alternatives. It explores the potential of health promotion and disease prevention, which can contribute significantly to a reduction of the disease burden and thus the need for medicines, both for infectious and for noncommunicable disease. Eco‐directed sustainable prescribing practices are reviewed, which have been adopted successfully to reduce the use of harmful pharmaceuticals. We note recent developments in medicines optimization and precision medicine, which hold promise for improving patient outcomes, saving costs, and reducing pharmaceutical use, through individually tailored prescribing whereby the patient codecides their therapy. Waste prevention through reuse or redistribution is beginning to find public support and “take‐back” waste disposal schemes set up via extended producer responsibility systems have achieved high returns. Finally, the paper summarizes preferred advanced wastewater technologies, including innovative low‐cost, low‐energy options. In summary, although end‐of‐pipe options have a role to play, particularly for highly concentrated wastewaters, solutions further up the medicinal chain and disease prevention interventions, informed by a broad view of health and health care, are needed to pursue a much greater potential reduction of pharmaceuticals in the environment than can be achieved by end‐of‐pipe solutions alone. Environ Toxicol Chem 2023;00:1–11. © 2023 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC.
Subject
Health, Toxicology and Mutagenesis,Environmental Chemistry
Reference84 articles.
1. Afdeling Strategie en Beleid. (2017).Evaluatie van het project: Milieubewust medcijnen voorscrhijven door huisartsen in Meppel.Waterschap Drents Overijsselse Delta.
2. Alejandre J. C. Chan Y. F. N. Frascaroli G. Forough A. S. Ignacio M. L. Singleton J. Pfleger S. Price L. Irvine K. N. Chastin S. &Helwig K.(2022 November 1–2).Behaviour change interventions employed in pharmaceutical prescribing programmes that have the potential to reduce environmental impact of medicines: Case studies from China The Netherlands and Sweden[Conference presentation]. 2022 Planetary Health Annual Meeting Boston MA United States.
3. Intentions to “reuse” medication in the future modelled and measured using the theory of planned behavior;Alhamad H.;Pharmacy: Journal of Pharmacy Education and Practice,2020
4. Green Chemistry: Principles and Practice
5. Healthy Lifestyle Interventions to Combat Noncommunicable Disease—A Novel Nonhierarchical Connectivity Model for Key Stakeholders: A Policy Statement From the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献